Desna Therapeutics focuses on precision immune tolerance and develops durable, antigen specific tolerizing therapeutics for autoimmune and severe allergic diseases. Our HepTol™ platform uses a cell-targeted mRNA LNP to leverage the body’s natural processes to establish disease specific immune tolerance and has shown efficacy in a variety of disease models. The mechanism of action and therapeutic constituents have all proven safe and effective in the clinic, minimizing translational risk. We are at the preclinical stage with our lead therapeutic. Our team of experienced biotech executives and drug developers has built and exited multiple companies and brought multiple therapeutics to market.
Company Details
- Employees
- 2
- Address
- Autoimmune Diseases.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://desnatherapeutics.com/
- Keywords
- Pharmaceutical Manufacturing.
Desna Therapeutics Questions
Desna Therapeutics's website is https://desnatherapeutics.com/
Desna Therapeutics's LinkedIn profile is https://www.linkedin.com/company/desna-therapeutics
Desna Therapeutics has
2 employees.
View email and phone details for 2
employees at Desna Therapeutics.
Desna Therapeutics's industry is
Biotechnology Research
Desna Therapeutics's top competitors are
Capstan Therapeutics,
Arrowhead Pharmaceuticals,
Lucina Biotherapeutics,
Valfard Therapeutics,
Wall Township Public Schools,
Cirsium Biosciences,
Six Therapeutics Inc.,
Ajinomoto Bio-Pharma Services,
Nsights Fsp,
Curamir Therapeutics, Inc..
Desna Therapeutics's categories are Biotechnology Research
